Drug Delivery Devices | US | 2017 | Market Analysis
Drug delivery devices are an important portion of drug development considerations with the ascent of biologic drugs that can no longer be provided in the form of an oral capsule. Growth in patient populations and expanding indications for drug delivery devices will drive revenue growth through 2025.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for drug delivery devices in the US across a 10-year period.
Growth in the injection device market is driven by new product development and the emergence of generic drugs, which increases the indications for these devices.
How will innovative devices, such as needle-free injection systems, contribute to the growth of the injection device market?
How will developments in transdermal patches and subcutaneous implants hinder the growth of the injection device market?
For which drug(s) will generics be developed for use in injection devices?
What strategies will allow competitors to gain revenue in this growing market?
Smart devices, such as the Smartinhaler, have become popular due to their convenience and ability to provide personalized treatment.
What do industry experts think about the adoption of smart devices in the future?
How will the development of smart devices impact the drug delivery device market?
Several new drug delivery technologies remain in development, including microneedle transdermal patches and subcutaneous implants.
What kinds of conditions are these new devices targeting?
Which products hold the greatest promise for successful adoption after launch?
How will the launch of new products influence transdermal patch ASPs and competitor dynamics?
What considerations must be taken into account for new competitors intending to enter the market?
